Dr. Asim Rizvi, MD

Dr. Rizvi practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Rizvi's NPI, 1265099014, was assigned on May 28, 2019. Dr. Rizvi graduated from Allama Iqbal Medical College in 2002. Dr. Rizvi holds Texas license T3372.

Dr. Rizvi's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Rizvi's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizvi practices. Vendor and product names are available with a free account.

Nephrology is Dr. Rizvi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Rizvi's licenses on file in 2 states: Texas and Ohio.

CMS data shows 478 Medicare services from Dr. Rizvi across 6 procedure codes in 2024, for 190 Medicare patients. Medicare paid $35,859 for them.

CMS counts 190 Medicare patients who saw Dr. Rizvi in 2024. The largest group is under 65, with 109 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 5.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizvi's median patient age at 60, with 46% women.

In 2024, Dr. Rizvi wrote 1,911 Medicare Part D claims for 261 patients. 93% of them were for generic drugs. CMS names the drug for 1,668 of them, across 26 drugs with 11 or more claims each, at $68,243 in total drug cost. In 2023, CMS named 1,714 claims across 28 drugs.

Dr. Rizvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 88 papers to Dr. Rizvi, published from 2011 to 2025. 2018 was the busiest year, with 14. The most frequent topics are Coronary Artery Disease, Coronary Angiography and Computed Tomography Angiography. Dr. Rizvi has published most often in JACC Cardiovasc Imaging. Dr. Rizvi's most frequent co-authors are Fay Y. Lin, MD, Kavitha M. Chinnaiyan, MD and Matthew J. Budoff, MD.

CMS Open Payments shows 18 general payments to Dr. Rizvi from 6 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $174.

Dr. Rizvi graduated from Allama Iqbal Medical College in 2002.

Dr. Rizvi is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.